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ABSTRACT 
Intracellular Ca2+ regulates diverse cellular functions in almost all the cells. In 
the pancreatic β-cells, Ca2+ signals are critical for insulin secretion. An increase 
in the cytoplasmic free Ca2+ concentration ([Ca2+]i) triggers insulin secretion. 
Multiple mechanisms increase the [Ca2+]i in the β-cells, and in this respect 
depolarization of the plasma membrane and consequent Ca2+ entry through the 
voltage-gated Ca2+ channels is particularly important. For depolarization of β-
cells the closure of KATP channels is essential. In addition, cation channels 
belonging to Transient Receptor Potential (TRP) family are thought to play 
important roles in causing depolarization. Previous studies have reported that the 
Transient Receptor Potential Melastatin-like subtype 5 (TRPM5) channel, a Ca2+ 
activated monovalent cation channel, is involved in the stimulus-secretion 
coupling in the mouse β-cells. We aimed to study the role of the TRPM5 channel 
in regulating insulin secretion, and [Ca2+]i in the rat β-cells.  
Another focus of this thesis was to evaluate a new human inluinoma cell line as a 
model for studying Ca2+ signaling in the β-cells. Recently a genetically 
engineered human insulinoma cell line (EndoC-BH1) has been developed.  We 
studied Ca2+ signaling in the EndoC-BH1 cells, in an attempt to assess whether 
these cells could be used as a model for this purpose. 
For inhibiting the TRPM5 channels we used triphenyl phosphine oxide (TPPO), 
a selective and potent pharmacological inhibitor of the channel. We measured 
insulin secretion from the islets from Sprague-Dawley rats in batch incubations. 
For measuring [Ca2+]i from single rat β-cells and EndoC-BH1 cells, we used 
fura-2 based ratiometric microfluorometry.  
We found that TPPO did not inhibit insulin secretion triggered by KCl, or 
fructose but it significantly reduced insulin secretion in response to glucose, L-
arginine, and GLP-1. It also significantly inhibited the KATP channel-independent 
insulin secretion by glucose. TPPO significantly inhibited the [Ca2+]i  increase in 
response to L-arginine. It also inhibited the [Ca2+]i increase triggered by glucose 
in a KATP channel independent mechanism. However, TPPO did not alter the 
[Ca2+]i response triggered by KCl, fructose, glucose and GLP-1.   
 ii 
We stimulated the EndoC-BH1 cells with gluocse, GLP-1, KCl, carbachol, L-
arginine, and tolbutamide. These agents that are known to increase [Ca2+]i  in the 
primary β-cells also increased [Ca2+]i in the these human insulinoma cells. 
Moreover, we found that GLP-1 was essential for eliciting Ca2+ response in the 
EndoC-BH1 cells upon stimulation by tolbutamide and glucose.  
We conclude that in the rat islets, TRPM5 plays an important role in mediating 
insulin secretion by glucose, and L-arginine, and in potentiating the glucose-
induced insulin secretion by GLP-1. We also conclude that the EndoC-BH1cells 
responds by [Ca2+]i  increase upon stimulation by several well-known agonists.  
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1 Introduction 
1.1 Islets of Langerhans 
 
Paul Langerhans, a German pathologist, was the first to describe these 
microstructures in the pancreas in 1869, but he failed to identify their function. 
Later in 1893, Edouard Laguesse, a French histologist, coined the name ‘islets of 
Langerhans’ and suggested that these could produce hormones that lowers 
hyperglycemia.  
Pancreas houses two different types of tissues, namely the exocrine and the 
endocrine tissues. Islets of Langerhans are the endocrine tissues, and they are 
more number in the body and tail regions of the pancreas. Islets contain at least 
five types of cells including the α-cells that secrete glucagon, β-cells that secrete 
insulin, δ-cells that secrete the growth hormone inhibiting hormone, 
somatostatin, pancreatic polypeptide producing (PP) cells, and ghrelin producing 
epsilon cells (1). β-cells sense the change in plasma nutrient concentration and in 
responses secrete insulin to maintain glucose homeostasis in the blood.  
Failure of the β-cells to secrete adequate insulin results in diabetes, a 
heterogeneous metabolic disorder associated with high blood glucose. Diabetes 
is classified mainly into two types, namely the type-1 diabetes mellitus and the 
type-2 diabetes mellitus. Type-1 diabetes is an autoimmune disorder in which β-
cells are killed by the immune system. Type-2 diabetes is associated with 
progressive β-cell dysfunction in secreting insulin due to aging or developing 
insulin resistance. Studying the physiology of β-cells may give a clearer picture 
about the pathogenesis of diabetes, and may also be useful in identifying 
therapeutic targets for the treatment of the disorder.   
1.2 Ca2+ as a signaling ion  
An increase in the free cytoplasm Ca2+ concentration ([Ca2+]i ) plays pivotal role 
in many cellular processes that include triggering insulin exocytosis in β-cells 
(2), fertilization of eggs (3), and enhancing ATP synthesis in the mitochondria 
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(4). Many in vitro experiments on resting β-cells showed that the concentration 
of Ca2+ in the cytoplasm is ~ 20-100 nM, whereas the extracellular concentration 
is ~1-2 mM. A local increase in [Ca2+]i  could be a trigger for a global [Ca2+]i  
increase (5). The entry, duration of presence, and exit of  the Ca2+ from the 
cytoplasm is regulated by many channels, pumps, ion exchangers, Ca2+-binding 
proteins, and other organelles (6).  
1.3 Ca2+ signaling in the β-cells 
Channels present on the plasma membrane like the receptor operated Ca2+ 
channels, store operated Ca2+ channels, and voltage gated Ca2+ channels (VGCC) 
regulate the Ca2+ entry from extracellular space in to the β-cells. The Ca2+ influx, 
through the L-type VGCCs in response to extracellular glucose is a predominant 
and a well-established mechanism (7). [Ca2+]i  is also regulated by store operated 
Ca2+ entry, in which the reduction in the Ca2+ in the ER (Ca2+ store) is sensed by 
the stromal interaction molecule (STIM), that translocates itself to the plasma 
membrane to activate the Orai1 channel to allow Ca2+ entry (8).  
In  the G-protein coupled receptor (GPCR) signaling, agonists like acetylcholine 
bind to the GPCRs to activate phospholipase C (PLC) followed by hydolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) to form 1,4,5-inositol trisphosphate 
(IP3) and  diacylglycerol (DAG). The IP3 binds to the 1,4,5-inositol trisphosphate 
receptor (IP3R) activating the channel to mobilize Ca2+ from the ER Ca2+ stores 
into the cytoplasm (9). IP3R and ryanodine receptors (RyR) are activated or 
inhibited by Ca2+ depending on the concentration of [Ca2+]i (10). The Ca2+ entry 
through the VGCCs activates the RyRs to mobilize Ca2+ from the endoplasmic 
reticulum to further amplify the Ca2+ signals; this process is called Ca2+ induced 
Ca2+ release (CICR)(11).   
Sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) replenishes the Ca2+ stores 
in the endoplasmic reticulum (12). The mitochndrial Ca2+ buffering (13; 14) and 
efflux of Ca2+ across the plasma membrane through plasma membrance Ca2+ 
ATPase, sodium-calcium exchangers also regulate the [Ca2+]i (15), thereby 
preventing the Ca2+ toxicity in the β-cells. The activation of several TRP 
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channels also regulates the [Ca2+]i  either by providing background depolarizing 
current or by permeating Ca2+ ions through them (6).   
1.4 Stimulus-secretion coupling in the β-cells 
The adult human islets comprise 70-80 % of β-cells that play critical role in the 
maintenance of blood glucose level. The β-cells also act as sensors for fatty 
acids, amino acids, neurotransmitters, growth factors incretins and other 
hormones. Insulin exocytosis in β-cells require an increase in the [Ca2+]i. 
Stimulus-secretion coupling in the pancreatic β-cells includes a combination of 
metabolic and electrical signaling cascades. After consumption of a meal, blood 
glucose concentration increases. Glucose is carried in to the β-cells through 
specific glucose transporters (GLUT 2 in rodents, and GLUT 1 and 3 in 
humans). Glucose is metabolized via glycolysis in the cytoplasm to produce 
adenosine triphosphate (ATP) and pyruvic acid. This pyruvic acid in turn is 
metabolized via the tricarboxylic acid (TCA) cycle in the mitochondria to 
produce ATP. The combined ATP production from glycolysis and TCA cycle 
increases the ATP/ADP ratio in the cytoplasm (16; 17).   
ATP sensitive K+ channels (KATP) that are present on the plasma membrane is 
the primary sensor that couples the metabolic changes exerted by glucose to 
electrical activity, and finally to secretion of insulin from the β-cells. KATP 
channel comprises of sulphonylurea receptor (SUR1), and four pore forming 
subunits KIR6.2, member of inward rectifier superfamily (7).  
The increase in the ATP/ADP ratio in the cytoplasm causes closure of the KATP 
channels that prompts cell membrane depolarization; the change in membrane 
potential activates the voltage gated Ca2+ channels (VGCCs) that allows entry of 
Ca2+ into the cytoplasm. The increase in the [Ca2+]i near the plasma membrane 
triggers insulin exocytosis (Fig. 1).  
Upon reduction in plasma glucose concentration, the decrease in the ATP/ADP 
ratio increases the opening probability of the KATP channels causing 
repolarization that acts as a feedback mechanism to stop insulin secretion. 
Diazoxide, opens the KATP channels to prevent depolarization of plasma 
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membrane, which makes it a therapeutic tool for treating hyperinsulinism (18). 
Closure of the KATP channels is an undisputed signaling event in plasma 
membrane depolarization. However, the KATP channel closure alone is not 
adequate to depolarize the membrane. An additional inward depolarizing 
currents caused by other ion channels present on the membrane is essential to 
depolarize the plasma membrane. It is thought that some members of the TRP 
family of channels may account for these inward depolarizing currents. 
 
Fig 1. stimulus-secretion coupling in the β-cell. The figure shows the cell organelles, 
ion channels, pumps, exchangers, and transporters involved in the regulation of 
stimulus-secretion coupling. ADP-Adenosine diphosphate; ATP- Adenosine 
triphosphate;CICR-Ca2+ induced Ca2+ increase; DAG-diacylglycerol; ER-Endoplasmic 
reticulum; GK-Glucokinase; GLUT- Glucose transporter; GPCR – G protein coupled 
receptors;  IP3- inositol 1,4,5-trisphosphate; IP3R- inositol 1,4,5-trisphosphate receptor; 
KATP-ATP sensitive K+ channel; KCa-Calcium activated K+ channels; MC-
Mithochondria; NCX- Na+-Ca2+ exchanger; PIP2- Phosphatidylinositol 4,5-
Molecular mechanisms involved in the generation of calcium signals in insulin secreting cells. 
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bisphosphate; PI-PLC- phosphatidyl inositol specific phospholipase C; PKC-protein 
kinase C; PMCA- Plasma membrane Ca2+ ATPase;  RyR-Ryanodine receptor; SERCA- 
Sarco-endoplasmic reticulum Ca2+ ATPase; SU-Sulphonylurea; SUR1-Suplhonylurea 
receptor 1; TCA cycle- tricarboxylic acid cycle; TRPM5- Transient Receptor Potential 
Melastatin-like subtype 5; VGCC-Voltage gated Ca2+ channel. 
1.5 KATP channel independent insulin secretion 
The closure of the KATP channels and depolarization of the plasma membrane are 
important events in stimulus-secretion coupling. In glucose stimulated insulin 
secretion (GSIS), there are other coupling factors apart from KATP channels in 
bringing about plasma membrane depolarization and insulin secretion. In the 
presence of diazoxide, which is known to activate the KATP channels and 
hyperpolarizes the plasma membrane (19),  glucose fails to, depolarize the 
plasma membrane, and secrete insulin from the mouse islets.  However, in the 
presence of high concentration of K+, glucose potentiates insulin secretion even 
in the presence of diazoxide (20) proving that glucose can amplify insulin 
secretion without involving the KATP channel activity. This validates that glucose 
initiates insulin secretion via a KATP channel dependent manner, and further 
amplifies insulin secretion in a KATP independent manner.   
1.6 TRP channels 
Transient receptor potential (TRP) channels were first discovered in Drosophila. 
A mutation of an ion channel in the photoreceptor cells elicited a transient 
change in membrane potential in response to continuous light and thus the name 
transient receptor potential channels (21). So far 28 TRP (27 in human) channels 
have been found and they are classified into two groups and seven sub families. 
Group A contains five subfamilies TRPC (canonical), TRPV (vanilloid), TRPM 
(melastatin), TRPA (ankyrin), and TRPN. Group B contains two subfamilies 
TRPP (polycystic) and TRPML (mucolipin) (22). The transmembrane topology 
of TRP channels show that TRP channels have six transmembrane sections with 
a pore forming unit between the 5th and 6th transmembrane domain. TRP 
channels are involved in perceiving various types of sensory reception that 
includes mechanoreception, thermoreception, chemoreception, and 
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photoreception. β-cells are found to express at least 13 TRP channels and among 
them TRPM2, TRPM3, TRPM4 and TRPM5 are thought to play important roles 
in insulin secretion in the β-cells in the rodents (23) 
1.6.1 TRPM5 gene and its expression 
The human TRPM5 gene was first described in 2000 by Enklaar and his co-
workers (24; 25). The human TRPM5 gene is located on the chromosome 11, 
and it contains 24 exons composed of 1165 amino acids whereas, the mouse 
TRPM5 gene is located on chromosome seven, and composed of 1158 amino 
acids.  
1.6.2 TRPM5 channel associated functions 
TRPM5 is a monovalent cation channel that is permeable to Na+, K+, Cs+ and 
Li+. The channel is activated by voltage, [Ca2+]i, phosphoinositide-4,5-
bisphosphate (PIP2) and heat (15 and 35ºC) (26). TRPM5 has been best studied 
in the taste cells where it is associated with sensing sweet, umami and bitter 
tastes (27; 28). The expression of TRPM5 in the stomach and small intestine are 
thought to be associated with chemosensation in the post ingestion process (29).  
TRPM5 is also shown to be play important roles in sensing of odors in mice 
(30).   
1.6.3 Pharmacological tools for the study of TRPM5 channel  
A major challenge in determining the physiological role or the TRPM5 channel 
is the lack of availability of potent and specific pharmacological tools. 
Flufenamic acid, a non-steroidal anti-inflammatory drug, inhibits TRPM5, 
however, it also inhibits the closely related TRPM4 channel with a 10 fold 
higher affinity (31). Quinine, a natural alkaloid and a bitter tastant, inhibits 
TRPM5 channel (32), along with inhibiting other ion channels (33; 34). 
Spermine, a polyamine, inhibits TRPM7 along with TRPM4 and TRPM5 in the 
micromolar range (35; 36).  
Triphenyl phosphine oxide (TPPO) inhibited TRPM5 currents in a concentration 
dependent manner, in HEK 293 cells transfected with human TRPM5 
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(hTRPM5) or mouse TRPM5 (mTRPM5) gene. TPPO at 100 µM concentration 
did not inhibit the closely related hTRPM4b, hTRPV1, hTRPA1, and TRPM4, 
which shows TPPO’s high selectivity for the TRPM5 channel. Triphenyl 
phosphine (TPP) that has similar geometric shapes, volume and surface area to 
that of TPPO, did not inhibit the TRPM5 channels. TPPO features high negative 
charge above the oxygen atom (Fig. 2) that is thought to be the prime factor 
involved in the inhibition of TRPM5 channel (37). TPPO has made it convenient 
to study the roles of the TRPM5 channel in stimulus-secretion coupling in the  
β-cells. 
 .   
Fig.2. The figure shows the chemical structure of triphenyl phosphine (TPP) (left) and 
triphenyl phosphine oxide (TPPO) (right). 
1.6.4 Role of TRPM5 in [Ca2+]i  increase and insulin secretion 
TRPM5 channels provide inward depolarizing current that is believed to 
contribute to depolarization and thereby Ca2+ influx in to the cytoplasm. TRPM5 
knockout mice exhibited the lack of glucose induced fast oscillation in 
membrane potential and [Ca2+]i. The islets from these mice secreted less insulin 
in response to glucose stimulation (38). In the same knockout mice model, 
TRPM5 mediated depolarization is proposed to be coupled with nutrient and L-
arginine mediated insulin secretion in the β-cells (39; 40). Until now, 
understanding of the physiological role of TRPM5 channel in insulin secretion is 
dominated by data obtained from knockout mice from a single source (38-40). It 
should also be noted that drawing conclusion about the role of the TRPM5 
channel, derived from a model devoid of TRPM5 gene from the embryonic stage 
can be deceiving. To further elucidate the role of TRPM5 in insulin secretion in 
response to different stimuli, more studies using different approaches and 
different animal models are needed. In our studies, using trphenylphosphine 
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oxide (TPPO), a selective TRPM5 channel inhibitor, we have examined the role 
of TRPM5 channel in mediating insulin secretion and [Ca2+]i  levels in the rat 
islets and primary rat β-cells respectively. 
1.7 Genetically engineered human β-cells 
Insulinoma cell lines offer many possibilities to study the signaling mechanisms, 
and stimulus-secretion coupling in the context of the pathophysiology of 
diabetes. For decades, the availability of wide range of insulinoma cell lines 
from rodents (41) played important roles in the β-cell research. These cell lines 
are used to overcome the limited availability of primary rodent or human β-cells. 
However, it should be noted that these cell lines are not from human origin. 
Conclusion from the data obtained from rodent cell lines can be misleading in 
understanding the physiological processes of β-cells in humans. Recently, a new 
functional human β-cell model has been established (42). These cells are 
obtained by transfecting the oncogene SV40LT in human fetal pancreatic buds 
followed by grafting the transfected buds into severe combined 
immunodeficiency (SCID) mice. The transfected buds formed insulinomas that 
were expanded to generate the EndoC-BH1 cell lines (42). It is necessary to use 
such human insulinoma cells for Ca2+ studies to better understand the Ca2+ 
signaling and regulation of insulin secretion in the human β-cells. Until now, 
Ca2+ signaling has not been reported in these cells. In this thesis, we have studied 
whether the EndoC-BH1 can used as a model to study Ca2+ signaling and 
stimulus-secretion coupling in β-cells. 
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2 Materials and methods 
2.1 Cells 
2.1.1 EndoC-BH1 cells 
For experiments involving human cell lines we used the EndoC-BH1 cells, 
which was a gift from Philippe Ravassard and Raphael Scharfmann, Institut du 
cerveau et de la moelle, Biotechnology & biotherapy, France. EndoC-BH1 is a 
genetically engineered human β-cell line generated by transducing human fetal 
pancreatic buds by a lentiviral vector system followed by grafting in to severe 
combined Immuno-deficient (SCID) mice. The resulted pancreatic cells that 
expressed the oncogene Simian Virus 40 large T antigen (SV40LT) were 
transduced with human telomerase reverse transcriptase and then grafted into 
other SCID mice. The resulting β-cells were expanded in cultures to form cell 
lines (42).  
2.1.2 Culturing EndoC-BH1 cells 
The EndoC-BH1 cell were grown on matrigel/fibronectin-coated flasks. The cell 
culture support contained Dulbecco's Modified Eagle Medium (DMEM) high 
glucose (25 mM), penicillin (100 IU/ml) and streptomycin (100 µg/ml), 
fibronectin (2 µg/ml), and extracellular matrix (ECM) (1 % V/V). The volume of 
cell culture support was 2.5 ml for 25 cm² flask. The culture flask was coated 
with the cell culture support, and incubated for one hour in 5 % CO2 at 37 °C, 
before the cells were seeded. EndoC-BH1 cells were cultured in DMEM with 
glucose (5.5 mM), albumin from bovine serum fraction V (BSA) (2%w/v), 2-
mercaptoethanol (50 µM), nicotinamide (10 mM), transferrin (5.5 μg/ml), 
sodium selenite (6.7 ng/ml), penicillin (100 IU/ml) and streptomycin (100 
µg/ml). The cells were cultured in humidified incubator in 5% CO2 at 37⁰C. The 
medium were changed once in a week. The cells were passaged once every 
second week. The cells were seeded on glass coverslips that were already coated 
with the cell culture support. They were cultured for 3 days, and 12 hours prior 
to using them for measuring [Ca2+]i. They were changed to glucose-starving 
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medium containing DMEM with low glucose (2.8 mM), BSA (2%w/v), 2-
mercaptoethanol (50 µM), nicotinamide (10 mM), transferrin (5.5 μg/ml), 
sodium selenite (6.7 ng/ml), penicillin (100 IU/ml), and streptomycin (100 
µg/ml).  
2.2 Preparation of islets from rats 
Male Sprague-Dawley rats were purchased from Scanbur (Stockholm, Sweden). 
The rats were maintained in a 12 h (0600–1800 h) light/dark cycle with free 
access to water and standard laboratory chow. They were 2-3 months old and 
they weighed 250–350 g at the time they were used for experiments. The 
animals were killed by inhalation of CO2. Collagenase (0.1 % w/v) was injected 
into the pancreatic duct. The pancreas was then removed. Islets were isolated by 
collagenase digestion in Hank’s balanced salt solution followed by 
centrifugation, density gradient separation with Histopaque 1077, and 
Histopaque 1119. Islets were then handpicked under a stereomicroscope, and 
transferred to the petri dishes containing Roswell Park Memorial Institute 1640 
(RPMI-1640) medium, glutamine (2 mM), FBS (10 % v/v), benzylpenicillin 
(100 units/ml), streptomycin (100 µg/ml), and glucose (11 mM). They were then 
cultured free-floating for 24 h in an incubator at 37 °C in 5 % CO2. On the day of 
the experiments, the islets were transferred to petridishes containing 5 ml of 
Krebs-Ringer bicarbonate HEPES (KRBH) buffer containing HEPES (10 mM), 
BSA (0.2 %), and glucose (3.3 mM). The islets were preincubated in this 
solution for 30 min at 37 °C in 5 % CO2.  
2.2.1 Dispersion of rat islets 
Islets were dispersed by treating with trypsin EDTA (0.05 % w/v) for 3 min at 37 
ºC. The islets were then placed on ice to stop the trypsin effect, and then pipetted 
up and down ~ 20 times. The cells were cultured on glass coverslips for 24 hours 
in a humidified incubator in 5 % CO2 at 37 ºC in RPMI-1640 medium 
supplemented with FBS (2.5 % v/v), penicillin (50 units/ml), HEPES (10 mM), 
and streptomycin (50 µg/ml). 
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2.3 Ethical considerations 
All studies involving rat islets were approved by the Northern Stockholm ethical 
committee on experimental animal care, and performed in accordance with the 
guidelines of the Karolinska Institutet, and Swedish national board for laboratory 
animals. 
2.4 List of pharmacological tools used 
Name of the compund Effects Concentration 
used 
Paper 
Carbachol (cch) Muscarinic agonist 100 µM I,II 
Diazoxide (Dz) Opens KATP  channels 100 µM I 
Glucagon like peptide-1 
(GLP-1) 
 
Incretin hormone that 
potentiates insulin secretion 
and [Ca2+]i  increase in the 
presence of glucose 
50 nM 
 
I,II 
 
L-Arginine (Arg) 
 
Depolarizes plasma 
membrane  
20 mM I,II 
Potassium Chloride 
(KCl) 
Depolarizes plasma 
membrane  
25 mM 
 
I,II 
 
Tolbutamide (Tol) Closes KATP  channels 100 µM and 
500 µM 
II 
Triphenyl phosphine 
oxide (TPPO) 
Inhibits TRPM5 channel 100 µM I 
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2.5 Measurement of insulin secretion from the islets 
Islets of approximately similar sizes handpicked under microscope were chosen 
for all the experiments. In separate experiments we measured the insulin contents 
of the islets, and expressed the released insulin as percentage of the total insulin 
content. We found that insulin content of the islets were not highly variable. 
Islets of similar sizes were incubated in groups of three in 300 µl KRB buffer 
containing glucose (3.3 or 16.7 mM) with or without other pharmacological 
agents, for one hour at 37 °C on a shaking water bath. After incubation of the 
islets, the supernatant was removed, and stored at -20 ºC. Total insulin content 
was measured after sonication of the islets for 10–15 s, followed by extraction of 
insulin overnight at 4 °C in acid-ethanol (70 % v/v). Immunoreactive insulin was 
measured by radioimmunoassay using polyclonal insulin antibodies (Fitzgerald 
Inc, USA), and rat insulin as standard (43).  
2.6 Measurement of insulin secretion from the EndoC-BH1 cells 
The EndoC-BH1 cells were seeded in a 24 well plate that were first coated with 
the cell culture support. The cells were seeded at a density of 226 000 cells/cm2. 
After seeding, the cells were grown for 48 h in DMEM medium with glucose 
(5.5 mM), BSA (2%w/v), 2-mercaptoethanol (50 µM), nicotinamide (10 mM), 
transferrin (5.5 μg/ml), sodium selenite (6.7 ng/ml), penicillin (100 IU/ml) and 
streptomycin (100 µg/ml). After that, the cells were incubated overnight in the 
glucose-starving medium containing DMEM with low glucose (2.8 mM), BSA 
(2%w/v), 2-mercaptoethanol (50 µM), nicotinamide (10 mM), transferrin (5.5 
μg/ml), sodium selenite (6.7 ng/ml), penicillin (100 IU/ml) and streptomycin 
(100 µg/ml). On the day of the experiments, the cells were incubated in KRBH 
buffer supplemented with glucose (0.5 mM) for one hour, and then with an 
increasing concentrations of glucose 0.5, 2.8, 5.6, 11, 16.7 and 25 mM glucose. 
The cells were incubated in 37°C at 5% CO2 for one hour. After the incubation, 
the supernatant was removed, and stored at -20 ºC. Total insulin content was 
measured after extraction of insulin overnight at 4 °C in acid-ethanol (70 % v/v). 
Immunoreactive insulin was measured by radioimmunoassay using polyclonal 
insulin antibodies (Fitzgerald Inc, USA), and human insulin as standard.  
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2.7 Measurement of [Ca2+]i by microfluorometry  
Cells grown on glass coverslips were incubated for 40 min in 2 ml of the 
‘loading buffer’ consisting of RPMI-1640 medium, and BSA (2 %) along with 
fura-2-acetoxymentyl ester (fura-2 AM) (1 µM) (life technologies, Stockholm, 
Sweden). The glass coverslips were then incubated for another 15 min in 
modiﬁed KRBH buffer containing NaCl (140 mM), KCl  (3.6  mM), NaH2PO4 
(0.5 mM), MgSO4.7H2O (0.5 mM), CaCl2 (1.5 mM), HEPES (10 mM), glucose 
(3 mM) and BSA (0.1%) (pH 7.4)  to let the endogenous esterases hydrolyze the 
AM ester. The coverslip was then mounted at the base of an open perifusion 
chamber, which was then placed on the stage of an inverted microscope (CK 40, 
Olympus Inc, Germany). The modified KRBH buffer containing different 
pharmacological agents was perfused by a peristaltic pump. A water bath and a 
thermistor connected to the perifusion chamber were used to control the 
temperature of the solution in the perifusion chamber. It takes about 58 seconds 
for the new solution to reach the perfusion chamber.   
For measurement of [Ca2+]i from single β-cells, we chose only the large cells to 
exclude the non-β-cells as much as possible. The fluorescence was measured by 
dual wavelength excitation fluorometry. The monochromator (PhotoMed 
DeltaRam) has a diffraction grating that spatially separates the colors of white 
light emitted from xenon lamp. The generated lights of wavelengths 340 nm and 
380 nm were directed onto the cells by a dichroic mirror. The emitted light 
chosen by a 510 nm filter was detected by the photomultiplier tube detector, and 
monitored by the Felix32 software (Photon Technology International, Inc).  
The block diagram of the fluorescence microscope system is shown in fig. 3. The 
cells loaded with fura-2 were excited at 340 nm and 380 nm alternately. The 
ratios between the emitted fluorescence intensities upon excitations at 340 nm 
and 380nm (F340/F380) were calculated by the Felix32 software. One 
F340/F380 data point per second was recorded. The background fluorescence 
was measured by removing the cell from the area of the study. The background 
was subtracted from the traces before calculation of [Ca2+]i. For calibration, 
Rmin and Rmax were determined from external standards containing fura-2 free 
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acid, and sucrose (2 M) (44). The Kd for Ca2+-fura-2 was taken as 225 nM. 
[Ca2+]i was calculated from F340/F380, Rmin and Rmax as described before 
(45).  
 
 
Fig.3. The model of the fluorescent microscopy apparatus used to measure 
[Ca2+]i : 1- Arc lamp housing; 2-Adjustable slits; 3-Excitation monochromator; 
4-Liquid light guide; 5-Liquid light guide adapter; 6-Microcope; 7-Microscope 
photometer; 8-Adjustible iris; 9-viewing eyepiece; 10-filter holder; 11-
photmultiplier tube detector. 
2.8 Statistical Analysis 
Results were expressed as means ± SEM. Student’s paired or unpaired t-test, or 
Chi-square test, as appropriate, were used for statistical tests of significance. P-
value < 0.05 was considered as significant.  
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3 Results and Discussion 
The detailed description of results, and discussion of their interpretation are in 
the published paper, and the manuscript that makes up this thesis. In this section, 
I shall briefly mention some of the key experiments from the manuscripts. 
3.1 Study I 
3.1.1 Role of the TRPM5 channels in insulin secretion and Ca2+ signaling 
in the rat β-cells.  
We studied the role of the TRPM5 channel in insulin secretion from rat islets and 
Ca2+ signaling from rat pancreatic β-cells. From the preliminary experiments 
done in our lab, we found that TPPO did not affect the tolbutamide induced 
[Ca2+]i increase, and [Ca2+]i  increase in response to depolarization by KCl. This 
shows that TPPO does not affect the activity of the VGCC’s. TPPO, did not 
increase [Ca2+]i by itself in the primary rat β-cells making this compound a 
suitable pharmacological tool to study the TRPM5 channel.  
TPPO inhibited the glucose induced insulin secretion from the rat islets. Our 
results were in line with previous reports that showed impaired insulin secretion 
in TRPM5 knockout mice (38; 40). However, in our study TPPO did not affect 
the glucose induced [Ca2+]i increase. The difference in the experimental 
conditions could account for this apparent discrepancy. The insulin secretion was 
measured from whole islets over a period of one hour, whereas [Ca2+]i was 
measured from single β-cells for only 500 s. Colsoul et al (2010) (38), showed 
that the absence of TRPM5 reduced the frequency of glucose induced Ca2+ 
oscillations in the intact mouse islets. In our Ca2+ experiments we used single β-
cells which usually do not show Ca2+ oscillations as seen in the intact islets.  
One of the major finding in our study was that TPPO reduced both the KATP 
channel-independent insulin secretion and [Ca2+]i increase in response to glucose 
(Fig. 4a, 4b, and 4c), as tested by the commonly used KCl plus diazoxide 
protocol (46). Thus, TRPM5 channels seem to play an important role in the 
insulin secretion by glucose, by the KATP channel independent mechanism. 
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Fig. 4. TPPO inhibited the KATP channel-independent insulin secretion and [Ca2+]i 
increase by glucose. (A) Islets were stimulated by glucose (16.7 mM) plus KCl (25 mM) 
with diazoxide (Dz) (100 µM), in the presence of TPPO (100 µM) (white bar), or in the 
absence of TPPO (black bar). TPPO inhibited the KATP channel independent insulin 
secretion by glucose (P < 0.005, n = 12). (B) The trace shows the changes in [Ca2+]i  in 
a single rat β-cell stimulated first with glucose (16.7 mM), plus KCl (25 mM) plus 
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diazoxide (100 µM), in the presence of TPPO (100 µM), and after washout, with glucose 
(16.7 mM), KCl (25 mM),  and diazoxide (100 µM). (C) The bars show the maximal 
[Ca2+]i  increase obtained by stimulation by glucose (16.7 mM) plus KCl (25 mM) with 
diazoxide (100 µM), in the presence of TPPO (100 µM) (white bar), or in the absence of 
TPPO (black bar). The data were derived from experiments shown in Fig 4B. TPPO 
inhibited the KATP channel independent [Ca2+]i increase by glucose (P < 0.05, n = 8). 
The presence of fructose together with a stimulatory concentration of glucose, 
further amplifies the insulin secretion (47). TRPM5 has been shown to be 
involved in this process in the mouse islets (39). In our experiments TPPO did 
not inhibit either fructose mediated insulin secretion or [Ca2+]i increase 
suggesting that in the rat islets, TRPM5 was not involved in insulin secretion in 
response to this hexose. In this respect, our results contradict the results reported 
by Kyriazis et al (2012) (39), who demonstrated that TRPM5 is involved in 
insulin secretion in response to fructose in mouse β-cells. The reason for this 
discrepancy is unclear. These authors have studied insulin secretion using islets 
from TRPM5 knockout mice, while we have used a pharmacological tool to 
study insulin secretion form rat islets. Thus, species differences, and differences 
in the experimental approach, may partly explain the differences in the results 
obtained.  
Another important finding in our study was that TRPM5 was involved in L-
arginine induced insulin secretion and [Ca2+]i  increase. L-arginine is a 
commonly used tool for in vitro mechanistic studies of stimulus-secretion 
coupling and [Ca2+]i signaling in the β-cells (48). It is postulated that L-arginine, 
which is a cationic amino acid, depolarizes the plasma membrane upon entering 
into the β-cell, without requiring metabolism of the amino acid. However, this 
view may be over simplistic. We found that TPPO markedly reduced, but did not 
completely inhibit the L-arginine induced insulin secretion and [Ca2+]i increase 
(Fig. 5a, 5b,and 5c). These results indicate that while L-arginine alone can 
increase [Ca2+]i partially, maximal increase of [Ca2+]i by the amino acid requires 
a second event, namely, the activation of the TRPM5 channel by the initial 
increase of [Ca2+]i caused by L-arginine. 
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Fig. 5. TPPO inhibited insulin secretion, and [Ca2+]i increase by L-arginine. (A) Rat 
islets were stimulated by L-arginine (Arg) (20 mM) without TPPO (black bar), and with 
TPPO (100 μM) (white bar) in the presence of glucose (7 mM). TPPO inhibited L-
arginine-stimulated insulin secretion by ~ 40 % (P < 0.05, n = 8). (B) The trace shows 
the changes in [Ca2+]i  in a single rat β-cell stimulated by L-arginine (20mM), first 
without TPPO, and then after washout, with TPPO (100 μM). Glucose (7 mM) was 
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present throughout the experiment. TPPO inhibited the L-arginine-induced [Ca2+]i 
response in a reversible manner in all experiments. (C) The figure shows the maximal 
[Ca2+]i increase obtained by L-arginine (20 mM) without TPPO (black bar), or with 
TPPO (100 µM) (white bar). TPPO inhibited L-Arginine-induced [Ca2+]i increase by ~ 
48 % (P < 0.05, n = 5). The data were derived from experiments similar to one shown in 
Fig.5B. 
GLP-1 makes the β-cells competent to stimulation by glucose, GLP-1 has been 
shown to exert its insulinotropic effect via various mechanisms, including 
depolarizing plasma membrane by closure of the KATP channels (49),  Ca2+ influx 
through Ca2+ channels present on the endoplasmic reticulum (50), and activation 
of non-specific cation channels (51). In this context, another important finding in 
our study was that TPPO significantly inhibited the GLP-1 potentiated GSIS 
(Fig. 6a). This suggests that TRPM5 may be involved in mediating the action of 
this incretin hormone. It is noteworthy that GLP-1 stimulates Na+ entry through 
non-selective cation channels in the plasma membrane (52), which could be 
TRPM5. We also found that while TPPO inhibited the insulin secretion, it did 
not inhibit the [Ca2+]i  response triggered by glucose plus GLP-1(Fig 6b, and 6c). 
This is consistent with the fact that GLP-1 mediates its actions primarily by 
activating the cAMP dependent pathways, rather than the Ca2+ signaling 
pathways. It remains a possibility that GLP-1 elicited a local Ca2+ signaling 
which was not detectable by our method, which measured the global [Ca2+]i 
changes.  
In summary, Our results suggest that in the rat islets TRPM5 is involved in 
mediating insulin secretion in response to glucose, GLP-1, and high 
concentration of L-arginine, but not in response to fructose. We speculate that 
TRPM5 is one of the many putative channels that provide the so called inward 
depolarizing “leak current”. Thus, increased activity of the TRPM5 could make 
the β-cells more readily electrically excitable by the incretin hormones. 
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Fig. 6. Effect of TPPO on GLP-1-induced insulin secretion and [Ca2+]i changes. (A) 
Rat islets were stimulated by glucose (16.7 mM), and GLP-1 (50 nM) without TPPO 
(white bar), and with TPPO (100 µM) (black bar). GLP-1 increased insulin secretion by 
~3 fold compared to that by 16.7 mM glucose alone (checked bar). Stimulation of 
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insulin secretion by GLP-1 (white bar) was inhibited by TPPO (black bar) (P < 0.05, n 
= 8). (B) The trace shows [Ca2+]i changes in a β-cell elicited by glucose (16.7 mM) plus 
GLP-1 (50 nM) without TPPO in the first stimulation, and then after washout, by the 
same agents in the presence of TPPO (100 μM). (C) The figure shows the maximal 
[Ca2+]i increase obtained by glucose (16.7 mM) plus GLP-1 (50 nM) without TPPO 
(100 µM) (black bar), or with TPPO (100 µM) (white bar).  TPPO did not inhibit the 
[Ca2+]i increase by glucose plus GLP-1 (P > 0.05, n = 7). The data were derived from 
experiments similar to one shown in Fig. 6B.  
It should be noted that we used only one pharmacological tool, namely TPPO, 
which is relatively new. It is possible that this pharmacological tool may have 
other effects which we still do not know. For instance, it may inhibit glucose 
metabolism. However this possibility is less likely, because glucose increased 
[Ca2+]i  in the presence of TPPO. It is however unclear why TPPO inhibited 
insulin secretion in spite of the fact that it did not inhibit [Ca2+]i . One possibility 
is that glucose induced [Ca2+]i  increase does not activate the TRPM5 in the 
presence of TPPO leading to sub-optimal depolarization, both [Ca2+]i  and 
depolarization are necessary for optimal insulin secretion. 
In spite of the fact that our conclusion is based on the results obtained by using 
one pharmacological tool, our results are convincing given that previous studies  
also reported reduced insulin secretion in TRPM5 knockout mice. 
3.2 Study II 
3.2.1 Insulin secretion and Ca2+ signaling in a genetically engineered 
human pancreatic β-cell line 
The development of genetically engineered human insulinoma cell lines that can 
be easily cultured and propagated has opened up possibilities for studying signal 
transduction in the β-cells. In this study, we demonstrate insulin secretion in 
EndoC-BH1 cells in response to glucose, GLP-1 and we show for the first time 
that [Ca2+]i can be measured from these cells by using fura-2 based 
microfluorometry. We have shown that several physiological or pharmacological 
agonists that are known to increase [Ca2+]i in the primary β-cells also increase 
[Ca2+]i in the EndoC-BH1 cells. 
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3.2.2 Insulin secretion in EndoC-BH1 cells 
Glucose stimulated the insulin secretion in a concentration dependent manner in 
the EndoC-BH1cells (Fig 7a). These cells secreted more insulin in response to 
glucose (16.7 mM) and GLP-1 (50 nM) compared to glucose (16.7 mM) alone 
(Fig. 7b), suggesting that the metabolic coupling pathways involved in glucose 
and GLP-1 stimulated insulin secretion were intact in these cells. 
  
Fig. 7.  Glucose stimulated insulin secretion in the EndoC-BH1cells. (A) The figure 
shows the magnitude of insulin secretion from EndoC-BH1cells in response to various 
glucose (Glu) concentrations.(B) Insulin secreted in response to glucose (16.7 mM) 
(white bar) and glucose (16.7 mM) plus GLP-1 (50 nM) (black bar).  
3.2.3 [Ca2+]i  signaling in the EndoC-BH1 cells 
KCl, which is known to depolarize the plasma membrane and activate VGCCs 
increased [Ca2+]i in the fura-2 loaded EndoC-BH1cells proving the presence of 
functional VGCCs in these cells. They also responded to the cholinergic agent 
carbachol indicating that the PI-PLC-IP3 pathway for Ca2+ signaling was intact 
in these cells. The cationic amino acid L-arginine also increased [Ca2+]i  in the 
EndoC-BH1 cells.  
Sulphonylureas are known to increase the [Ca2+]i primarily by inhibiting the 
KATP channels and thereby causing depolarization followed by activation of 
VGCC. We found that, Tolbutamide, a commonly used sulphonylurea, increased 
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[Ca2+]i in the presence of GLP-1 (Fig. 8a) indicating that EndoC-BH1 cells 
possess functional KATP channels and voltage-gated Ca2+ channels. GLP-1 was 
essential for eliciting Ca2+ response in the EndoC-BH1 cells upon stimulation by 
glucose (Fig. 8b). These observations are consistent with the fact that GLP-1 
makes β-cells competent to glucose (49). However, we found that even in the 
presence of GLP-1 the [Ca2+]i  response to glucose in the EndoC-BH1 cells was 
small compared to that reported in the primary human β-cell (53). It should be 
noted that, Insulin secretion in response to glucose is poor (or absent) in most of 
the rodent insulinoma cell lines available. These observations prove that the ion 
channels and the signaling molecules that are essential for the regulation of the 
membrane potential and Ca2+ signaling in the primary β-cells are present also in 
the EndoC-BH1 cells. We conclude that EndoC-BH1 cells could be used as a 
model to study stimulus-secretion coupling and Ca2+ signaling in the human β-
cells.  
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Fig. 8. GLP-1 makes EndoC-BH1 cells competent (A) The representative trace 
shows increase in [Ca2+]i when stimulated with tolbutamide (100 µM) plus GLP-
1 (50 nM) (n = 5). (B) The representative trace shows increase in [Ca2+]i when 
stimulated with glucose (16.7 mM) plus GLP-1 (50 nM), KCl (25 mM) was used 
as a positive control. (n = 17). 
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4 Conclusions 
• The TRPM5 channel is involved in insulin secretion and [Ca2+]i  increase 
in response to glucose, L-arginine and GLP-1, but not in response to 
fructose.  
 
• The genetically engineered human β-cell line (EndoC-BH1) could be 
used as a model for studying stimulus-secretion coupling and Ca2+ 
signaling in the human β-cells. 
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5 Future perspectives 
It is important to study the molecular mechanisms of the regulation and function 
of other TRP channels present in the β-cells in mediating insulin secretion. 
Future research could focus on developing more potent and selective 
pharmacological tools for the TRP channels. The use of such tools may provide 
answers for many unsolved questions. It is possible that TRP channels could be 
possible therapeutic targets for the treatment of type-2 diabetes.  
The EndoC-BH1 cells are of human origin, these cells have good insulin 
secreting properties in response to glucose. Future research could be intensified 
to find out whether these cells could be used for β-cell transplantation.  
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